Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 26, Issue 26, Pages 3737-3749
Publisher
Baishideng Publishing Group Inc.
Online
2020-07-14
DOI
10.3748/wjg.v26.i26.3737
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergistic inhibition of pancreatic cancer with anti-PD-L1 and c-Myc inhibitor JQ1
- (2019) Yu Pan et al. OncoImmunology
- PRMT1 promotes pancreatic cancer growth and predicts poor prognosis
- (2019) Chao Song et al. CELLULAR ONCOLOGY
- The Protein Arginine Methyltransferases 1 and 5 affect Myc properties in glioblastoma stem cells
- (2019) Annarita Favia et al. Scientific Reports
- PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation
- (2018) Xin Yao Qiu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Protein arginine methyltransferase 1 coordinates the epithelial-mesenchymal transition/proliferation dichotomy in gastric cancer cells
- (2018) Youli Zhang et al. EXPERIMENTAL CELL RESEARCH
- Recent advances in targeting protein arginine methyltransferase enzymes in cancer therapy
- (2018) Emily Smith et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Arginine methylation regulates c-Myc–dependent transcription by altering promoter recruitment of the acetyltransferase p300
- (2017) Irina Tikhanovich et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Development of Potent Type I Protein Arginine Methyltransferase (PRMT) Inhibitors of Leukemia Cell Proliferation
- (2017) Chen Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- PD-L1 Expression in Pancreatic Cancer
- (2017) Lei Zheng JNCI-Journal of the National Cancer Institute
- The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
- (2017) Chunwan Lu et al. JNCI-Journal of the National Cancer Institute
- UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients
- (2017) Corina T. Madreiter-Sokolowski et al. Oncotarget
- BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
- (2017) Simon J. Hogg et al. Cell Reports
- PD-L1 Expression in Pancreatic Cancer
- (2017) Lei Zheng JNCI-Journal of the National Cancer Institute
- The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
- (2017) Chunwan Lu et al. JNCI-Journal of the National Cancer Institute
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated Methylation
- (2016) Yan Wang et al. CANCER RESEARCH
- IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
- (2016) Thomas A Mace et al. GUT
- Concepts to Target MYC in Pancreatic Cancer
- (2016) M. Wirth et al. MOLECULAR CANCER THERAPEUTICS
- MYC regulates the antitumor immune response through CD47 and PD-L1
- (2016) S. C. Casey et al. SCIENCE
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer
- (2015) Kristin J. Lastwika et al. CANCER RESEARCH
- Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients
- (2015) Bolag Altan et al. Gastric Cancer
- PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response
- (2015) Hsin-Wei Liao et al. JOURNAL OF CLINICAL INVESTIGATION
- MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies
- (2015) E Hessmann et al. ONCOGENE
- Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression
- (2014) Chunxiao Xu et al. CANCER CELL
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- Disruption of CD8+ Treg Activity Results in Expansion of T Follicular Helper Cells and Enhanced Antitumor Immunity
- (2014) D. A. Alvarez Arias et al. Cancer Immunology Research
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now